We are live on ! Find out more

Micro Cap Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
PLUR icon
176
Pluri
PLUR
$17.6M
$17.6M $1.63 6.86%
KALA icon
177
KALA BIO
KALA
$17.1M
$17.1M $0.8840 4.63%
LPCN icon
178
Lipocine
LPCN
$17M
$17M $2.06 1.44%
PTN
179
Palatin Technologies
PTN
$16.8M
$16.8M $9.47 27.8%
KTTA icon
180
Pasithea Therapeutics
KTTA
$16.4M
$16.4M $0.4900 2.7%
HIND
181
Vyome Holdings
HIND
$15.6M
$15.6M $2.22 1.33%
COCP icon
182
Cocrystal Pharma
COCP
$15.4M
$15.4M $1.12 3.7%
PASG icon
183
Passage Bio
PASG
$14.8M
$14.8M $4.59 2%
CMMB
184
Chemomab Therapeutics
CMMB
$14.1M
$14.1M $1.92 1.05%
PDSB icon
185
PDS Biotechnology
PDSB
$13.5M
$13.5M $0.2420 5.76%
ICU icon
186
SeaStar Medical
ICU
$13.4M
$13.4M $3.36 8.94%
BCDA icon
187
BioCardia
BCDA
$13.1M
$13.1M $0.8800 5.59%
PBM icon
188
Psyence Biomedical
PBM
$12.8M
$12.8M $3.35 1.47%
AKTX
189
Akari Therapeutics
AKTX
$12.6M
$12.6M $7.18 7.12%
PHIO icon
190
Phio Pharmaceuticals
PHIO
$12.5M
$12.5M $1.08 0.92%
QNRX
191
Quoin Pharmaceuticals
QNRX
$11.8M
$11.8M $5.89 10.1%
BIVI icon
192
BioVie
BIVI
$11.8M
$11.8M $1.56 22.8%
BLRX
193
BioLineRX
BLRX
$11.7M
$11.7M $2.69 3.24%
KPRX icon
194
Kiora Pharmaceuticals
KPRX
$11.7M
$11.7M $2.64 0.76%
SNTI icon
195
Senti Biosciences Holdings
SNTI
$11.7M
$11.7M $0.3752 5.01%
VTGN icon
196
VistaGen Therapeutics
VTGN
$11.6M
$11.6M $0.2612 2.94%
INTS icon
197
Intensity Therapeutics
INTS
$11.2M
$11.2M $4.16 0.95%
GTBP icon
198
GT Biopharma
GTBP
$10.9M
$10.9M $0.3021 3.42%
LNAI
199
Lunai Bioworks
LNAI
$10.7M
$10.7M $2.35 2.08%
LSTA icon
200
Lisata Therapeutics
LSTA
$10.6M
$10.6M $1.18 2.48%
6 7
8
9 10

Micro Cap Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 273 micro cap Biotechnology stocks — companies in the Biotechnology industry with a market cap under $250M — worth a combined $18.3B.

The largest by market cap are Greenwich LifeSciences (GLSI) at $248M, Adagene (ADAG) at $248M and Capricor Therapeutics (CAPR) at $243M.

Among institutional investors, Atrium Therapeutics (RNA) drew the most net new fund positions in Q1 2026: 162 funds opened new positions.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.